Drug Topics November 9, 2024
Stephen Schondelmeyer, PharmD, PhD, FAPhA, gave a presentation on US drug shortages and their global implications.
In order to ensure the safety and integrity of the US drug supply chain, it’s important for all parties acting within it to consider the drugs themselves as critical infrastructure to the country as a whole, not just within the pharmaceutical industry. With so much of the active pharmaceutical ingredients (APIs) of drugs being imported from other countries like India and China, drug shortages have become an increasingly significant issue that threatens the fabric of critical infrastructure within the US.
“The first point I want to make is drugs are critical infrastructure, and drug shortages have created a real challenge for us. When you...
Today's Sponsors
Today's Sponsor